Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1987 Nov;70(2):255–262.

The human NK cell--a short over-view and an hypothesis on NK recognition.

M Jondal 1
PMCID: PMC1542099  PMID: 2892600

Full text

PDF
255

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allavena P., Klein R., Ortaldo J. R. Characterization of human large granular lymphocyte subpopulations: comparison of the phenotype of NK cells and of interleukin 2-dependent progenitors of cytolytic effector cells. Nat Immun Cell Growth Regul. 1985;4(1):7–20. [PubMed] [Google Scholar]
  2. Allavena P., Scala G., Djeu J. Y., Procopio A. D., Oppenheim J. J., Herberman R. B., Ortaldo J. R. Production of multiple cytokines by clones of human large granular lymphocytes. Cancer Immunol Immunother. 1985;19(2):121–126. doi: 10.1007/BF00199719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Berke G. Cytotoxic T-lymphocytes. How do they function? Immunol Rev. 1983;72:5–42. doi: 10.1111/j.1600-065x.1983.tb01071.x. [DOI] [PubMed] [Google Scholar]
  4. Biron C. A., Natuk R. J., Welsh R. M. Generation of large granular T lymphocytes in vivo during viral infection. J Immunol. 1986 Mar 15;136(6):2280–2286. [PubMed] [Google Scholar]
  5. Blumenthal R., Millard P. J., Henkart M. P., Reynolds C. W., Henkart P. A. Liposomes as targets for granule cytolysin from cytotoxic large granular lymphocyte tumors. Proc Natl Acad Sci U S A. 1984 Sep;81(17):5551–5555. doi: 10.1073/pnas.81.17.5551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bolhuis R. L., Roozemond R. C., van de Griend R. J. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor. J Immunol. 1986 Jun 1;136(11):3939–3944. [PubMed] [Google Scholar]
  7. Dustin M. L., Sanders M. E., Shaw S., Springer T. A. Purified lymphocyte function-associated antigen 3 binds to CD2 and mediates T lymphocyte adhesion. J Exp Med. 1987 Mar 1;165(3):677–692. doi: 10.1084/jem.165.3.677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Grimm E. A., Thoma J. A., Bonavida B. Mechanism of cell-mediated cytotoxicity at the single cell level. II. Evidence for first-order kinetics of T cell-mediated cytolysis and for heterogeneity of lytic rate. J Immunol. 1979 Dec;123(6):2870–2877. [PubMed] [Google Scholar]
  9. Grossman Z., Herberman R. B. Natural killer cells and their relationship to T-cells: hypothesis on the role of T-cell receptor gene rearrangement on the course of adaptive differentiation. Cancer Res. 1986 Jun;46(6):2651–2658. [PubMed] [Google Scholar]
  10. Imboden J. B., Stobo J. D. Transmembrane signalling by the T cell antigen receptor. Perturbation of the T3-antigen receptor complex generates inositol phosphates and releases calcium ions from intracellular stores. J Exp Med. 1985 Mar 1;161(3):446–456. doi: 10.1084/jem.161.3.446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jondal M., Kullman C., Alter M. B., Ljunggren K. Natural killer and T-cell potentiation by monoclonal IgG against natural killer cell FcR(IgG) or the T3 complex. Scand J Immunol. 1986 Jun;23(6):639–645. doi: 10.1111/j.1365-3083.1986.tb01999.x. [DOI] [PubMed] [Google Scholar]
  12. Jondal M., Kullman C., Rossi P., Lindgren J. A. Second messenger function of arachidonic acid lipoxygenation products in human natural killer cell lysis? Scand J Immunol. 1985 Sep;22(3):285–293. doi: 10.1111/j.1365-3083.1985.tb01883.x. [DOI] [PubMed] [Google Scholar]
  13. Jondal M., Pross H. Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations. Int J Cancer. 1975 Apr 15;15(4):596–605. doi: 10.1002/ijc.2910150409. [DOI] [PubMed] [Google Scholar]
  14. Kadish A. S., Doyle A. T., Steinhauer E. H., Ghossein N. A. Natural cytotoxicity and interferon production in human cancer: deficient natural killer activity and normal interferon production in patients with advanced disease. J Immunol. 1981 Nov;127(5):1817–1822. [PubMed] [Google Scholar]
  15. Katz P., Zaytoun A. M., Fauci A. S. Deficiency of active natural killer cells in the Chediak-Higashi syndrome. Localization of the defect using a single cell cytotoxicity assay. J Clin Invest. 1982 Jun;69(6):1231–1238. doi: 10.1172/JCI110562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Katz P., Zaytoun A. M., Lee J. H., Jr, Panush R. S., Longley S. Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event. J Immunol. 1982 Nov;129(5):1966–1971. [PubMed] [Google Scholar]
  17. Kiessling R., Klein E., Wigzell H. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol. 1975 Feb;5(2):112–117. doi: 10.1002/eji.1830050208. [DOI] [PubMed] [Google Scholar]
  18. Krensky A. M., Sanchez-Madrid F., Robbins E., Nagy J. A., Springer T. A., Burakoff S. J. The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions. J Immunol. 1983 Aug;131(2):611–616. [PubMed] [Google Scholar]
  19. Lanier L. L., Cwirla S., Phillips J. H. Genomic organization of T cell gamma genes in human peripheral blood natural killer cells. J Immunol. 1986 Dec 1;137(11):3375–3377. [PubMed] [Google Scholar]
  20. Lanier L. L., Kipps T. J., Phillips J. H. Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen). J Exp Med. 1985 Dec 1;162(6):2089–2106. doi: 10.1084/jem.162.6.2089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lanier L. L., Le A. M., Civin C. I., Loken M. R., Phillips J. H. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol. 1986 Jun 15;136(12):4480–4486. [PubMed] [Google Scholar]
  22. Lanier L. L., Phillips J. H., Hackett J., Jr, Tutt M., Kumar V. Natural killer cells: definition of a cell type rather than a function. J Immunol. 1986 Nov 1;137(9):2735–2739. [PubMed] [Google Scholar]
  23. Letvin N. L., King N. W., Reinherz E. L., Hunt R. D., Lane H., Schlossman S. F. T lymphocyte surface antigens in primates. Eur J Immunol. 1983 Apr;13(4):345–347. doi: 10.1002/eji.1830130414. [DOI] [PubMed] [Google Scholar]
  24. Lozzio C. B., Lozzio B. B. Cytotoxicity of a factor isolated from human spleen. J Natl Cancer Inst. 1973 Feb;50(2):535–538. doi: 10.1093/jnci/50.2.535. [DOI] [PubMed] [Google Scholar]
  25. Moy P. M., Holmes E. C., Golub S. H. Depression of natural killer cytotoxic activity in lymphocytes infiltrating human pulmonary tumors. Cancer Res. 1985 Jan;45(1):57–60. [PubMed] [Google Scholar]
  26. Neudorf S., Kersey J., Filipovich A. Lymphoid progenitor cells in severe combined immunodeficiency. J Clin Immunol. 1985 Jan;5(1):26–30. doi: 10.1007/BF00915165. [DOI] [PubMed] [Google Scholar]
  27. Oettgen H. C., Terhorst C., Cantley L. C., Rosoff P. M. Stimulation of the T3-T cell receptor complex induces a membrane-potential-sensitive calcium influx. Cell. 1985 Mar;40(3):583–590. doi: 10.1016/0092-8674(85)90206-5. [DOI] [PubMed] [Google Scholar]
  28. Ortaldo J. R., Herberman R. B. Heterogeneity of natural killer cells. Annu Rev Immunol. 1984;2:359–394. doi: 10.1146/annurev.iy.02.040184.002043. [DOI] [PubMed] [Google Scholar]
  29. Ortaldo J. R., Mason A. T., Gerard J. P., Henderson L. E., Farrar W., Hopkins R. F., 3rd, Herberman R. B., Rabin H. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects. J Immunol. 1984 Aug;133(2):779–783. [PubMed] [Google Scholar]
  30. Pandolfi F., Semenzato G., de Rossi G., Quinti I., Guglielmi C., Pezzutto A., Lopez M., Tonietti G., Fontana L., Abo T. HNK-1 monoclonal antibody (Leu-7) in the identification of abnormal expansions of large granular lymphocytes. Clin Exp Immunol. 1983 Jun;52(3):641–647. [PMC free article] [PubMed] [Google Scholar]
  31. Plunkett M. L., Sanders M. E., Selvaraj P., Dustin M. L., Springer T. A. Rosetting of activated human T lymphocytes with autologous erythrocytes. Definition of the receptor and ligand molecules as CD2 and lymphocyte function-associated antigen 3 (LFA-3). J Exp Med. 1987 Mar 1;165(3):664–676. doi: 10.1084/jem.165.3.664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Pross H. F., Baines M. G. Spontaneous human lymphocyte-mediated cytotoxicity againts tumour target cells. I. The effect of malignant disease. Int J Cancer. 1976 Nov 15;18(5):593–604. doi: 10.1002/ijc.2910180508. [DOI] [PubMed] [Google Scholar]
  33. Pross H. F., Jondal M. Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes. Clin Exp Immunol. 1975 Aug;21(2):226–235. [PMC free article] [PubMed] [Google Scholar]
  34. Ramstedt U., Serhan C. N., Nicolaou K. C., Webber S. E., Wigzell H., Samuelsson B. Lipoxin A-induced inhibition of human natural killer cell cytotoxicity: studies on stereospecificity of inhibition and mode of action. J Immunol. 1987 Jan 1;138(1):266–270. [PubMed] [Google Scholar]
  35. Robertson M. T-cell receptor. The present state of recognition. 1985 Oct 31-Nov 6Nature. 317(6040):768–771. doi: 10.1038/317768a0. [DOI] [PubMed] [Google Scholar]
  36. Rooney C. M., Wimperis J. Z., Brenner M. K., Patterson J., Hoffbrand A. V., Prentice H. G. Natural killer cell activity following T-cell depleted allogeneic bone marrow transplantation. Br J Haematol. 1986 Mar;62(3):413–420. doi: 10.1111/j.1365-2141.1986.tb02952.x. [DOI] [PubMed] [Google Scholar]
  37. Selvaraj P., Plunkett M. L., Dustin M., Sanders M. E., Shaw S., Springer T. A. The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3. 1987 Mar 26-Apr 1Nature. 326(6111):400–403. doi: 10.1038/326400a0. [DOI] [PubMed] [Google Scholar]
  38. Siliciano R. F., Pratt J. C., Schmidt R. E., Ritz J., Reinherz E. L. Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein. Nature. 1985 Oct 3;317(6036):428–430. doi: 10.1038/317428a0. [DOI] [PubMed] [Google Scholar]
  39. Svedmyr E., Jondal M. Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1622–1626. doi: 10.1073/pnas.72.4.1622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Takasugi M., Mickey M. R., Terasaki P. I. Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res. 1973 Nov;33(11):2898–2902. [PubMed] [Google Scholar]
  41. Takasugi M., Ramseyer A., Takasugi J. Decline of natural nonselective cell-mediated cytotoxicity in patients with tumor progression. Cancer Res. 1977 Feb;37(2):413–418. [PubMed] [Google Scholar]
  42. Trinchieri G., Perussia B. Human natural killer cells: biologic and pathologic aspects. Lab Invest. 1984 May;50(5):489–513. [PubMed] [Google Scholar]
  43. Ueda M., Harada M., Shiobara S., Nakao S., Kondo K., Odaka K., Matsue K., Mori T., Hattori K. T lymphocyte reconstitution in long-term survivors after allogeneic and autologous marrow transplantation. Transplantation. 1984 Jun;37(6):552–556. doi: 10.1097/00007890-198406000-00005. [DOI] [PubMed] [Google Scholar]
  44. Ullberg M., Jondal M. Recycling and target binding capacity of human natural killer cells. J Exp Med. 1981 Mar 1;153(3):615–628. doi: 10.1084/jem.153.3.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Vollger L. W., Tuck D. T., Springer T. A., Haynes B. F., Singer K. H. Thymocyte binding to human thymic epithelial cells is inhibited by monoclonal antibodies to CD-2 and LFA-3 antigens. J Immunol. 1987 Jan 15;138(2):358–363. [PubMed] [Google Scholar]
  46. Welsh R. M. Natural cell-mediated immunity during viral infections. Curr Top Microbiol Immunol. 1981;92:83–106. doi: 10.1007/978-3-642-68069-4_6. [DOI] [PubMed] [Google Scholar]
  47. Young J. D., Hengartner H., Podack E. R., Cohn Z. A. Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity. Cell. 1986 Mar 28;44(6):849–859. doi: 10.1016/0092-8674(86)90007-3. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES